FDA approves 2nd Alzheimer's drug that can modestly slow demetia

FDA approves 2nd Alzheimer's drug that can modestly slow demetia


Kisunla is not a cure and slows worsening memory and cognitive problems by about seven months.

https://www.pbs.org/newshour/health/fda-approves-2nd-alzheimers-drug-that-can-modestly-slow-demetia